| Sheila Treftz, APN | |
|
120 Spalding Dr, Suite 401, Naperville, IL 60540-6508 | |
| (630) 416-4501 | |
| (630) 416-4504 |
| Full Name | Sheila Treftz |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 23 Years |
| Location | 120 Spalding Dr, Naperville, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023074051 | NPI | - | NPPES |
| 209004336 | Other | IL | IL LICENSE NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LA2100X | Nurse Practitioner - Acute Care | 209004336 (Illinois) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sigma Health Pc | 2961305693 | 25 |
News Archive
As hospitals obtain new imaging equipment, it is essential to train and educate staff to ensure that they are able to use advanced technologies to help diagnose patients. A carefully planned and in-depth program is necessary to allow staff to stay at the forefront of medical imaging technology. Toshiba America Medical Systems, Inc. recognizes the importance of quality, in-depth education and guarantees customer satisfaction with the Performance Pro education approach.
A doctor who was one of the discoverers of the gene responsible for myotonic muscular dystrophy has now identified a therapeutic that could modify progression of muscle damage and muscle dysfunction associated with the disease - issues that cause patients significant disability and deterioration in quality of life.
This "re-equipping and re-emergence" of a clone that caused a pandemic 40-50 years ago could mean that community acquired MRSA will spread faster and be more widespread than previously expected, warns an international team of researchers who have been studying the bacteria.
Anadys Pharmaceuticals, Inc. announced today that it has entered into definitive agreements with certain institutional investors to raise approximately $12.5 million in gross proceeds in a "registered direct" offering through the sale of a total of 5,813,954 shares of its common stock at an offering price of $2.15 per share. Anadys estimates that net proceeds from the offering will be approximately $11.3 million, after deducting placement agents' fees and estimated offering expenses.
Pharmasset, Inc. announced today the pricing of an underwritten public offering of 3,300,000 shares of its common stock at an offering price of $46.33 per share. Of the shares being sold, Pharmasset is selling 2,300,000 shares and the selling stockholders are selling 1,000,000 shares. Pharmasset expects to receive net proceeds, after deducting the underwriting discount and estimated offering expenses, of approximately $101.5 million.
› Verified 1 days ago
| Entity Name | Edward Health Ventures |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962452912 PECOS PAC ID: 4284531484 Enrollment ID: O20031216000616 |
News Archive
As hospitals obtain new imaging equipment, it is essential to train and educate staff to ensure that they are able to use advanced technologies to help diagnose patients. A carefully planned and in-depth program is necessary to allow staff to stay at the forefront of medical imaging technology. Toshiba America Medical Systems, Inc. recognizes the importance of quality, in-depth education and guarantees customer satisfaction with the Performance Pro education approach.
A doctor who was one of the discoverers of the gene responsible for myotonic muscular dystrophy has now identified a therapeutic that could modify progression of muscle damage and muscle dysfunction associated with the disease - issues that cause patients significant disability and deterioration in quality of life.
This "re-equipping and re-emergence" of a clone that caused a pandemic 40-50 years ago could mean that community acquired MRSA will spread faster and be more widespread than previously expected, warns an international team of researchers who have been studying the bacteria.
Anadys Pharmaceuticals, Inc. announced today that it has entered into definitive agreements with certain institutional investors to raise approximately $12.5 million in gross proceeds in a "registered direct" offering through the sale of a total of 5,813,954 shares of its common stock at an offering price of $2.15 per share. Anadys estimates that net proceeds from the offering will be approximately $11.3 million, after deducting placement agents' fees and estimated offering expenses.
Pharmasset, Inc. announced today the pricing of an underwritten public offering of 3,300,000 shares of its common stock at an offering price of $46.33 per share. Of the shares being sold, Pharmasset is selling 2,300,000 shares and the selling stockholders are selling 1,000,000 shares. Pharmasset expects to receive net proceeds, after deducting the underwriting discount and estimated offering expenses, of approximately $101.5 million.
› Verified 1 days ago
| Entity Name | Sigma Health Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720035843 PECOS PAC ID: 2961305693 Enrollment ID: O20040130000006 |
News Archive
As hospitals obtain new imaging equipment, it is essential to train and educate staff to ensure that they are able to use advanced technologies to help diagnose patients. A carefully planned and in-depth program is necessary to allow staff to stay at the forefront of medical imaging technology. Toshiba America Medical Systems, Inc. recognizes the importance of quality, in-depth education and guarantees customer satisfaction with the Performance Pro education approach.
A doctor who was one of the discoverers of the gene responsible for myotonic muscular dystrophy has now identified a therapeutic that could modify progression of muscle damage and muscle dysfunction associated with the disease - issues that cause patients significant disability and deterioration in quality of life.
This "re-equipping and re-emergence" of a clone that caused a pandemic 40-50 years ago could mean that community acquired MRSA will spread faster and be more widespread than previously expected, warns an international team of researchers who have been studying the bacteria.
Anadys Pharmaceuticals, Inc. announced today that it has entered into definitive agreements with certain institutional investors to raise approximately $12.5 million in gross proceeds in a "registered direct" offering through the sale of a total of 5,813,954 shares of its common stock at an offering price of $2.15 per share. Anadys estimates that net proceeds from the offering will be approximately $11.3 million, after deducting placement agents' fees and estimated offering expenses.
Pharmasset, Inc. announced today the pricing of an underwritten public offering of 3,300,000 shares of its common stock at an offering price of $46.33 per share. Of the shares being sold, Pharmasset is selling 2,300,000 shares and the selling stockholders are selling 1,000,000 shares. Pharmasset expects to receive net proceeds, after deducting the underwriting discount and estimated offering expenses, of approximately $101.5 million.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sheila Treftz, APN 801 S Washington St, Naperville, IL 60540-7430 Ph: (630) 527-3000 | Sheila Treftz, APN 120 Spalding Dr, Suite 401, Naperville, IL 60540-6508 Ph: (630) 416-4501 |
News Archive
As hospitals obtain new imaging equipment, it is essential to train and educate staff to ensure that they are able to use advanced technologies to help diagnose patients. A carefully planned and in-depth program is necessary to allow staff to stay at the forefront of medical imaging technology. Toshiba America Medical Systems, Inc. recognizes the importance of quality, in-depth education and guarantees customer satisfaction with the Performance Pro education approach.
A doctor who was one of the discoverers of the gene responsible for myotonic muscular dystrophy has now identified a therapeutic that could modify progression of muscle damage and muscle dysfunction associated with the disease - issues that cause patients significant disability and deterioration in quality of life.
This "re-equipping and re-emergence" of a clone that caused a pandemic 40-50 years ago could mean that community acquired MRSA will spread faster and be more widespread than previously expected, warns an international team of researchers who have been studying the bacteria.
Anadys Pharmaceuticals, Inc. announced today that it has entered into definitive agreements with certain institutional investors to raise approximately $12.5 million in gross proceeds in a "registered direct" offering through the sale of a total of 5,813,954 shares of its common stock at an offering price of $2.15 per share. Anadys estimates that net proceeds from the offering will be approximately $11.3 million, after deducting placement agents' fees and estimated offering expenses.
Pharmasset, Inc. announced today the pricing of an underwritten public offering of 3,300,000 shares of its common stock at an offering price of $46.33 per share. Of the shares being sold, Pharmasset is selling 2,300,000 shares and the selling stockholders are selling 1,000,000 shares. Pharmasset expects to receive net proceeds, after deducting the underwriting discount and estimated offering expenses, of approximately $101.5 million.
› Verified 1 days ago
Ivy Millar Enger, APN-CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 100 Spalding Dr Ste 206, Naperville, IL 60540 Phone: 630-646-7250 Fax: 630-548-7743 | |
Angela Marie Jeffries, MSN CRNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 4043 S Route 59, Naperville, IL 60564 Phone: 630-420-4275 Fax: 630-420-8957 | |
Ella Pearl Zuniga, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 120 Spalding Dr Ste 205, Naperville, IL 60540 Phone: 630-491-8310 | |
Joann El Mahassni, APRN, FNP-BC, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1220 Hobson Rd Ste 232, Naperville, IL 60540 Phone: 630-946-6554 Fax: 877-458-3984 | |
Mrs. Krina Patel, MSN, APN, FNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1309 Macom Dr Ste 101, Naperville, IL 60564 Phone: 630-236-8018 Fax: 630-236-8949 | |
Ms. Amy Beth Reeb, NP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1315 Macom Dr, Ste. 203, Naperville, IL 60564 Phone: 630-898-4822 |